In the latest session, INVO Bioscience Inc (NASDAQ: INVO) closed at $0.76 down -0.91% from its previous closing price of $0.77. On the day, 42223 shares were traded.
Ratios:
For a deeper understanding of INVO Bioscience Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.31 and its Current Ratio is at 0.37. In the meantime, Its Debt-to-Equity ratio is 23.81 whereas as Long-Term Debt/Eq ratio is at 18.16.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.04 while its Price-to-Book (P/B) ratio in mrq is 5.05.
Stock Price History:
Over the past 52 weeks, INVO has reached a high of $10.96, while it has fallen to a 52-week low of $0.50.
Shares Statistics:
A total of 2.62M shares are outstanding, with a floating share count of 2.59M. Insiders hold about 0.96% of the company’s shares, while institutions hold 4.31% stake in the company.
Earnings Estimates
There are — different market analysts currently analyzing its stock. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.23. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with — analysts recommending between $0 and $0.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for INVO’s current fiscal year. The highest revenue estimate was $2.82M, while the lowest revenue estimate was $2.82M, resulting in an average revenue estimate of $2.82M. In the same quarter a year ago, actual revenue was $822k, up 243.10% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $8.44M in the next fiscal year. The high estimate is $8.44M and the low estimate is $8.44M. The average revenue growth estimate for next year is up 199.30% from the average revenue estimate for this year.
